JAMA Editors' Summary Encouraging Lung Cancer Screening for Eligible Patients, Treating Pediatric ITP, Bioresorbable Occluders for ASD, and more
Oct 24, 2025
Discover groundbreaking findings in lung cancer screening that show a program boosting CT scan completion rates. Learn about L‑TromboBag's promising results for treating pediatric ITP, enhancing platelet responses in children. Explore bioresorbable occluders, proving just as effective as metallic ones for ASD closure. Uncover how closed-loop insulin systems improve glucose control for pregnant patients. Plus, insights into healthcare worker challenges and the need for military-civilian partnerships in conflict health delivery.
AI Snips
Chapters
Transcript
Episode notes
Digital Outreach Raises Screening Rates
- Direct-to-patient digital programs can increase lung cancer screening uptake among eligible adults.
Consider New Oral Option For Pediatric ITP
- Consider L‑TromboBag as a treatment option for children with newly diagnosed ITP who need therapy.
Bioresorbable Occluders Match Metallic Devices
- Bioresorbable occluders performed noninferiorly to metallic devices for ASD closure at six months.